JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B8772 CFT8634

Summary: An orally active BRD9-targeting degrader for research on tumors such as synovial sarcoma.

≥44 mg/mL
A4408 SC 57461A

Summary: LTA4 hydrolase inhibitor,potent and selective

≥36.4 mg/mL
A4472 Mdivi 1
7 Citation

Summary: Selective DRP1/Dnm1 inhibitor, cell-permeable

insoluble in H2O; insoluble in EtOH; ≥17.65 mg/mL
A4505 Chetomin

Summary: A4505 inhibitor

soluble in DMSO
A4535 DL-AP3

Summary: Glutamate receptor antagonist and HPSP inhibitor

insoluble in DMSO; insoluble in EtOH; ≥12.05 mg/mL
A3965 BI 2536
2 Citation

Target: PLK|Bromodomain-containing proteins(BRDs)

Summary: Plk1 inhibitor,potent and ATP-competitive

insoluble in H2O; ≥13.04 mg/mL
A8228 Purmorphamine
3 Citation

Summary: Hedgehog agonist
A8240 SB 216763
3 Citation

Target: GSK-3

Summary: GSK-3 inhibitor,ATP-competitive,potent and selective

insoluble in EtOH; insoluble in H2O; ≥56.8 mg/mL
A1765 Vincristine sulfate

Target: Microtubule/Tubulin

Summary: Microtubule disrupter,antitumor agent

≥46.15 mg/mL
A1412 Clofarabine

Summary: Antimetabolite,inhibit DNA polymerase and ribonucleotide reductase

insoluble in H2O; insoluble in EtOH; ≥15.18 mg/mL